Heart Test Laboratories (HSCS) Competitors $2.55 -0.09 (-3.41%) (As of 10:15 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends HSCS vs. NURO, PXDT, PSTV, INBS, BTCY, CUTR, STSS, AEMD, CTCX, and CHEKShould you be buying Heart Test Laboratories stock or one of its competitors? The main competitors of Heart Test Laboratories include NeuroMetrix (NURO), Pixie Dust Technologies (PXDT), Plus Therapeutics (PSTV), Intelligent Bio Solutions (INBS), Biotricity (BTCY), Cutera (CUTR), Sharps Technology (STSS), Aethlon Medical (AEMD), Carmell (CTCX), and Check-Cap (CHEK). These companies are all part of the "medical equipment" industry. Heart Test Laboratories vs. NeuroMetrix Pixie Dust Technologies Plus Therapeutics Intelligent Bio Solutions Biotricity Cutera Sharps Technology Aethlon Medical Carmell Check-Cap Heart Test Laboratories (NASDAQ:HSCS) and NeuroMetrix (NASDAQ:NURO) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment, community ranking and analyst recommendations. Does the MarketBeat Community favor HSCS or NURO? NeuroMetrix received 280 more outperform votes than Heart Test Laboratories when rated by MarketBeat users. However, 80.00% of users gave Heart Test Laboratories an outperform vote while only 58.80% of users gave NeuroMetrix an outperform vote. CompanyUnderperformOutperformHeart Test LaboratoriesOutperform Votes480.00% Underperform Votes120.00% NeuroMetrixOutperform Votes28458.80% Underperform Votes19941.20% Is HSCS or NURO more profitable? Heart Test Laboratories has a net margin of 0.00% compared to NeuroMetrix's net margin of -203.71%. NeuroMetrix's return on equity of -42.56% beat Heart Test Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Heart Test LaboratoriesN/A -144.12% -94.48% NeuroMetrix -203.71%-42.56%-39.26% Do analysts rate HSCS or NURO? Heart Test Laboratories currently has a consensus target price of $15.00, indicating a potential upside of 488.24%. Given Heart Test Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Heart Test Laboratories is more favorable than NeuroMetrix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NeuroMetrix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor HSCS or NURO? In the previous week, Heart Test Laboratories and Heart Test Laboratories both had 1 articles in the media. Heart Test Laboratories' average media sentiment score of 0.00 equaled NeuroMetrix'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heart Test Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeuroMetrix 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in HSCS or NURO? 17.2% of Heart Test Laboratories shares are held by institutional investors. Comparatively, 19.4% of NeuroMetrix shares are held by institutional investors. 1.8% of Heart Test Laboratories shares are held by insiders. Comparatively, 7.3% of NeuroMetrix shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, HSCS or NURO? Heart Test Laboratories has a beta of 3.27, indicating that its share price is 227% more volatile than the S&P 500. Comparatively, NeuroMetrix has a beta of 2.29, indicating that its share price is 129% more volatile than the S&P 500. Which has preferable valuation and earnings, HSCS or NURO? NeuroMetrix has higher revenue and earnings than Heart Test Laboratories. NeuroMetrix is trading at a lower price-to-earnings ratio than Heart Test Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeart Test Laboratories$20K116.03-$6.61M-$21.64-0.12NeuroMetrix$5.90M1.48-$6.53M-$4.59-0.93 SummaryHeart Test Laboratories and NeuroMetrix tied by winning 8 of the 16 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Heart Test Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeart Test LaboratoriesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.41M$9.70B$5.06B$8.82BDividend YieldN/A1.10%5.18%4.07%P/E Ratio-0.1223.02126.3117.81Price / Sales129.5930.911,178.7474.57Price / CashN/A23.3733.8632.53Price / Book0.245.614.684.68Net Income-$6.61M$182.72M$119.54M$226.08M7 Day Performance0.38%38.40%-1.83%-1.04%1 Month Performance-27.47%54.60%-3.60%1.04%1 Year Performance-86.54%3.49%31.91%26.28% Heart Test Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeart Test Laboratories1.8615 of 5 stars$2.55-3.4%$15.00+488.2%-85.7%$2.32M$20,000.00-0.1210Gap DownNURONeuroMetrix0.5208 of 5 stars$4.27-1.6%N/A+11.5%$8.71M$5.90M0.0020Analyst ForecastNews CoveragePXDTPixie Dust Technologies1.9685 of 5 stars$0.58flat$5.21+798.3%N/A$8.63M$6.30M0.0078Upcoming EarningsPSTVPlus Therapeutics3.2157 of 5 stars$1.22+2.5%$14.00+1,047.5%-37.4%$7.20M$4.91M0.0020Analyst RevisionGap UpINBSIntelligent Bio Solutions0.3287 of 5 stars$1.55+10.7%N/A-61.1%$6.81M$3.11M0.0010News CoverageGap UpBTCYBiotricityN/A$0.29-6.5%N/A-66.9%$6.65M$12.06M-0.2340Analyst ForecastAnalyst RevisionNews CoverageCUTRCutera1.11 of 5 stars$0.31+2.7%$3.00+865.9%-86.7%$6.27M$212.37M-0.05430Analyst ForecastSTSSSharps Technology0.7782 of 5 stars$3.04-5.9%N/AN/A$5.47MN/A-0.383Gap DownAEMDAethlon Medical2.6602 of 5 stars$0.39-1.3%$7.00+1,718.2%-77.2%$5.38M$570,000.00-0.1410CTCXCarmellN/A$0.24-2.4%N/A-90.9%$5.02MN/A0.0014CHEKCheck-Cap0.5197 of 5 stars$0.77+0.8%N/A-76.9%$4.49MN/A-0.2780Upcoming EarningsNews CoverageGap Up Related Companies and Tools Related Companies NeuroMetrix Competitors Pixie Dust Technologies Competitors Plus Therapeutics Competitors Intelligent Bio Solutions Competitors Biotricity Competitors Cutera Competitors Sharps Technology Competitors Aethlon Medical Competitors Carmell Competitors Check-Cap Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HSCS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heart Test Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
